The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester).

The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors. Recordings from previous webinars are available here.

Dr Rabia Khan (Founder and CEO of Serna Bio)

In the September webinar of this series, hosted by Cambridge Academy of Therapeutic Sciences (CATS) on Tuesday 24th September from 2-3pm (via Zoom). Our guest speaker was Dr Rabia Khan, CEO of Serna Bio, who gave an exciting talk on the topic of “Mapping the Druggable Transcriptome: Lesson learned from AI-enabled RNA-small molecule drug discovery”

Topic: “Mapping the Druggable Transcriptome: Lesson learned from AI-enabled RNA-small molecule drug discovery”
Guest Speaker: Dr Rabia Khan (Founder and CEO of Serna Bio)
Date and Time: Tuesday 24^th September, from 2-3pm (on Zoom)

The webinar was chaired by Prof Anne Willis, OBE, OMRC Investigator and the Director of the MRC Toxicology Unit.

Recording for this webinar is not currently available but might be released in the coming months.

Related